Related Experiment Video
Updated: Jan 5, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Intracellular and Intercellular Mitochondrial Dynamics in Parkinson's Disease
Dario Valdinocci1, Rui F Simões2, Jaromira Kovarova3
1School of Medical Science, Griffith University, Southport, QLD, Australia.
Mitochondrial dysfunction is central to Parkinson's disease (PD) progression, impacting calcium levels and promoting alpha-synuclein aggregation. Impaired mitochondrial clearance and intercellular transfer may also contribute to PD pathology and neuronal loss.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Parkinson's disease (PD) is characterized by Lewy bodies and loss of catecholaminergic neurons.
- Mitochondrial dysfunction is a recognized key factor in PD progression.
- Mitochondrial dysfunction affects calcium homeostasis and increases intracellular calcium, particularly in dopaminergic neurons.
Purpose of the Study:
- To review the role of intracellular and intercellular mitochondrial dynamics in Parkinson's disease etiology.
- To discuss how mitochondrial dysfunction contributes to alpha-synuclein aggregation and neuronal loss.
- To explore the impact of mitochondrial transport and clearance defects in PD.
Main Methods:
- Literature review of recent studies on mitochondrial dynamics in Parkinson's disease.
- Analysis of the relationship between mitochondrial dysfunction, calcium homeostasis, and alpha-synuclein aggregation.
- Examination of evidence for impaired mitochondrial clearance and intercellular transfer in PD.
Main Results:
- Mitochondrial dysfunction elevates intracellular calcium, triggering alpha-synuclein aggregation.
- Increased reactive oxygen species (ROS) from mitochondrial defects contribute to aggregate formation and neurodegeneration.
- Defects in mitochondrial clearance and transport, including intercellular transfer, are implicated in PD pathology.
Conclusions:
- Mitochondrial dysfunction is a critical driver of Parkinson's disease pathogenesis.
- Both intracellular mitochondrial dynamics and intercellular transfer mechanisms are relevant to PD etiology.
- Targeting mitochondrial dysfunction presents a potential therapeutic avenue for Parkinson's disease.
Related Concept Videos
Mitochondrial Membranes
Parkinson's Disease: Overview
The Inner Mitochondrial Membrane
Mitochondria
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

